Skip to content

Freezing of Gait in Parkinson's Disease

Effect of Visuospatial Training Tasks on Freezing of Gait in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01887054
Acronym
FOG
Enrollment
30
Registered
2013-06-26
Start date
2013-06-30
Completion date
2014-08-31
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

This study is designed to evaluate whether a specific visuospatial training task will change gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of gait.

Detailed description

This study is a randomized, prospective, single-blinded six-week study in PD patients with freezing of gait (FOG). This study will involve 2 study groups: Group A - training group; Group B - no training group/controls. Both groups will complete a gait evaluation and neuropsychological testing. Group A will also practice an in-home visuospatial task for 30 minutes, 4-6 days per week for six weeks. Group B will not complete the in-home tasks. Participation in this study is expected to last 6-8 weeks.

Interventions

DEVICETower of Hanoi
OTHERPlacebo group - non use of Tower of Hanoi

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: greater than 18 years old and without an upper age limit * diagnosis of idiopathic PD exhibiting at least 2 or 3 cardinal signs (bradykinesia, rigidity, and resting tremor) * Ambulate independently without an assistive device for at least 60 meters * Freezing of gait episodes confirmed through the FOG-Q and evaluation by a fellowship trained Movement Disorder neurologist * Willingness and ability to participate in training and complete training diary * Documented FOG-Q and Unified Parkinson's Disease Rating Scale (UPDRS) II * Ability to sign informed consent * Pregnant females will be included in the study and there are no known risks to the pregnant female or fetus

Exclusion criteria

* Inability to complete questionnaires * Unwillingness to participate in training, complete all questionnaires and training diary * Subjects with secondary causes of parkinsonism * Significant dementia (MOCA \<20) * Prior deep brain stimulation (DBS) surgery or pallidotomy * Subjects cannot participate in any form of Physical Therapy, Occupational Therapy or Speech Therapy during the study period * Subjects cannot start any new medications during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Double Limb Support (DLS)6 weeksPrimary outcome will be the percent of the gait cycle spent in DLS. This will be evaluated using a GaitRite via a continuous walk, with subjects walking an 18-20 meter oval loop three times continuously.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026